Oxametacin or oxamethacin

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C19H17ClN2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8G02RSW5CM, chemically known as 1h-indole-3-acetamide, 1-(4-chlorobenzoyl)-n-hydroxy-5-methoxy-2-methyl- (9ci) but generally known as oxametacin, which bears US NIH Compound Identifier 33675. European Medicines Agency schedules Oxametacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09492MIG. The term OXAMETACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules oxametacin in its Anatomical Therapeutic Chemical (ATC) Classification. OXAMETACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Oxametacin or oxamethacin bears US NLM identifiers UMLS ID C2698676 and NCI Concept Code C76077. SMILES: CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)CL)C=CC(=C2)OC)CC(=O)NO.